Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 4INDUSTRY 2OTHER_GOV 1

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Pain 2

Interventions

Fentanyl 13Zoledronic Acid 8Ibandronic Acid 8nabiximols 6Oxycodone 6Tapentadol 5Morphine 4Hydromorphone 4Cryotherapy 4Cryosurgery 4alvimopan 3trimebutine 3-thiocarbamoylbenzenesulfonate 2resiniferatoxin 2cabozantinib 2Tetrodotoxin 2Radiation 2Prednisone 2Naloxone 2Diclofenac 2Analgesics, Opioid 26'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 2ziconotide 1oxycodone naloxone combination 1imisopasem manganese 1fulranumab 1Xylitol 1Ultracet 1Transdermal Patch 1Therapeutics 1Sufentanil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Pain × Analgesics, Opioid × Clear all
NCT03778450 2019-09-04

Long-term Opioid Therapy, Misuse and Mortality in Patients With Chronic Non-cancer Pain in Germany

LinkCare GmbH

Completed
3,232 enrolled

Pain

NCT00822614 2009-01-14

FINDS

Akela Pharma, Inc.

Phase 3 Unknown
500 enrolled

Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡